Clinical Cancer Bulletin

Springer Nature

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical Cancer Bulletin is an open-access journal published by Springer Nature in Singapore, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 17 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Nature
ISSN
2791-3937
Country
Singapore
Languages
english
Access
Open access
Articles in DOAJ
31
Declared review time
17 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2025-07-25
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
17 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

31

Most recent article

last month

Average review time (journal-declared via DOAJ)

17weeks

Works in OpenAlex

63

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

6

i10-index

3

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2025-07-25
Added to DOAJ
2025-07-25
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
99%
ORCID iDs in current deposits
63%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Ferroptosis and cancer prognosis
  • CAR-T cell therapy research
  • Ferroptosis and cancer prognosis
  • Lung Cancer Treatments and Mutations
Show all subjects (50)
  • Lung Cancer Treatments and Mutations
  • CAR-T cell therapy research
  • Lung Cancer Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lung Cancer Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • RNA modifications and cancer
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • RNA modifications and cancer
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Colorectal Cancer Treatments and Studies
  • HER2/EGFR in Cancer Research
  • Colorectal Cancer Treatments and Studies
  • Genetic factors in colorectal cancer
  • Pancreatic and Hepatic Oncology Research
  • Esophageal Cancer Research and Treatment
  • Genetic factors in colorectal cancer
  • HER2/EGFR in Cancer Research
  • Esophageal Cancer Research and Treatment
  • Virus-based gene therapy research
  • Breast Cancer Treatment Studies
  • RNA Research and Splicing
  • Gastric Cancer Management and Outcomes
  • Virus-based gene therapy research
  • RNA Research and Splicing
  • Pancreatic function and diabetes
  • Gastric Cancer Management and Outcomes
  • Multiple Myeloma Research and Treatments
  • Sarcoma Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Multiple Myeloma Research and Treatments
  • Cancer Cells and Metastasis
  • Sarcoma Diagnosis and Treatment

Keywords (DOAJ)

  • oncology
  • cancer treatment
  • clinical oncology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: